Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference

Aclaris Therapeutics (NASDAQ: ACRS) will present at the 2026 Bank of America Healthcare Conference in Las Vegas on May 14, 2026 at 9:35 AM PT.

Rhea-AI Summary

Aclaris Therapeutics (NASDAQ: ACRS) will present at the 2026 Bank of America Healthcare Conference in Las Vegas on May 14, 2026 at 9:35 AM PT. Dr. Hugh Davis, President and COO, will deliver the corporate presentation. A live and archived webcast will be available on the company website for at least 30 days.

Argus May 8 session

+1.44% close to close Open Argus

Details

News Market Reaction – ACRS

On May 8, the day this news came out, ACRS closed 1.44% above the previous close.

Data tracked by StockTitan Argus for the May 8 session.

Market Context

This announcement highlights Aclaris’s participation in a major healthcare investor conference on Ma...

Analysis

This announcement highlights Aclaris’s participation in a major healthcare investor conference on May 14, 2026, with a webcast available for at least 30 days. It fits an ongoing pattern of visibility efforts alongside recent clinical milestones for ATI-052 and ATI-2138 and recent SEC filings, including a larger quarterly net loss and capital raises. Investors may monitor future clinical readouts, additional financing steps, and further conference updates as key markers of execution.

Key Figures

Conference date: May 14, 2026 Presentation time: 9:35 AM PT Webcast availability: 30 days

Conference date

May 14, 2026

Scheduled Bank of America Healthcare Conference presentation

Presentation time

9:35 AM PT

Start time for corporate presentation

Webcast availability

30 days

Archived webcast duration on company website

Historical Context

5 past events · Latest: Apr 28

5 events

1. Apr 28

   Phase 1a results

   24h Move

   -4.3%

   Positive full top-line Phase 1a ATI-052 data and lead indication update.

2. Apr 27

   Clinical update notice

   24h Move

   -4.3%

   Announcement of upcoming ATI-052 results release and ATI-2138 indication selection.

3. Apr 08

   Conference participation

   24h Move

   +5.3%

   Participation in virtual inflammatory skin disease conference with management fireside chat.

4. Mar 27

   Phase 2a data

   24h Move

   +0.0%

   Presentation of Phase 2a ATI-2138 ePoster showing strong week-12 efficacy measures.

5. Mar 20

   Poster announcement

   24h Move

   -1.3%

   Announcement of upcoming Phase 2a ATI-2138 ePoster at AAD Annual Meeting.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WAYNE, Pa., May 08, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that on Thursday May 14, 2026, at 9:35 AM PT, Aclaris’ President and Chief Operating Officer Dr. Hugh Davis will provide a corporate presentation during the 2026 Bank of America Healthcare Conference in Las Vegas, NV.

A live and archived webcast of this event will be accessible on the Events page of the Aclaris website, www.aclaristx.com. The webcast will be available on the Aclaris website for at least 30 days.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on LinkedIn.

Aclaris Therapeutics Contact:

Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Aclaris Therapeutics (ACRS) present at the 2026 Bank of America Healthcare Conference?

Aclaris will present on May 14, 2026 at 9:35 AM PT. According to the company, the presentation is part of the conference schedule in Las Vegas and will be delivered by Dr. Hugh Davis, President and COO.

Who will deliver Aclaris's presentation at the 2026 Bank of America Healthcare Conference (ACRS)?

Dr. Hugh Davis, President and Chief Operating Officer, will provide the presentation. According to the company, he will speak on behalf of Aclaris during the scheduled May 14, 2026 session at 9:35 AM PT.

How can investors watch the Aclaris (ACRS) presentation from the Bank of America Healthcare Conference?

A live webcast will stream on the company's Events page at www.aclaristx.com. According to the company, the webcast will also be archived on the website for at least 30 days after the live presentation.

Will the Aclaris (ACRS) conference webcast be available after May 14, 2026?

Yes, the webcast will be archived on the company website for at least 30 days. According to the company, viewers can access the archived presentation via the Events page after the live May 14, 2026 session.

What topics will Aclaris (ACRS) likely cover in the May 14, 2026 presentation?

The announcement specifies a corporate presentation by the company's President and COO but does not list topics. According to the company, the presentation will be part of the Bank of America Healthcare Conference program in Las Vegas.